1. Home
  2. NKTR vs QUAD Comparison

NKTR vs QUAD Comparison

Compare NKTR & QUAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • QUAD
  • Stock Information
  • Founded
  • NKTR 1990
  • QUAD 1971
  • Country
  • NKTR United States
  • QUAD United States
  • Employees
  • NKTR 61
  • QUAD N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • QUAD Publishing
  • Sector
  • NKTR Health Care
  • QUAD Consumer Discretionary
  • Exchange
  • NKTR Nasdaq
  • QUAD Nasdaq
  • Market Cap
  • NKTR 948.8M
  • QUAD 304.4M
  • IPO Year
  • NKTR 1994
  • QUAD 2010
  • Fundamental
  • Price
  • NKTR $55.63
  • QUAD $6.81
  • Analyst Decision
  • NKTR Strong Buy
  • QUAD Strong Buy
  • Analyst Count
  • NKTR 6
  • QUAD 2
  • Target Price
  • NKTR $81.67
  • QUAD $9.30
  • AVG Volume (30 Days)
  • NKTR 1.2M
  • QUAD 227.2K
  • Earning Date
  • NKTR 11-06-2025
  • QUAD 10-27-2025
  • Dividend Yield
  • NKTR N/A
  • QUAD 4.41%
  • EPS Growth
  • NKTR N/A
  • QUAD N/A
  • EPS
  • NKTR N/A
  • QUAD N/A
  • Revenue
  • NKTR $74,934,000.00
  • QUAD $2,584,500,000.00
  • Revenue This Year
  • NKTR N/A
  • QUAD N/A
  • Revenue Next Year
  • NKTR N/A
  • QUAD N/A
  • P/E Ratio
  • NKTR N/A
  • QUAD N/A
  • Revenue Growth
  • NKTR N/A
  • QUAD N/A
  • 52 Week Low
  • NKTR $6.48
  • QUAD $4.34
  • 52 Week High
  • NKTR $52.75
  • QUAD $9.13
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 88.64
  • QUAD 59.83
  • Support Level
  • NKTR $42.12
  • QUAD $6.42
  • Resistance Level
  • NKTR $50.53
  • QUAD $7.08
  • Average True Range (ATR)
  • NKTR 3.76
  • QUAD 0.24
  • MACD
  • NKTR 1.39
  • QUAD 0.00
  • Stochastic Oscillator
  • NKTR 94.44
  • QUAD 62.36

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

Share on Social Networks: